These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 19679411

  • 21. Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
    O'Brien LD, Wills KL, Segsworth B, Dashney B, Rock EM, Limebeer CL, Parker LA.
    Pharmacol Biochem Behav; 2013 Jan; 103(3):597-602. PubMed ID: 23103902
    [Abstract] [Full Text] [Related]

  • 22. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats.
    Lichtman AH, Martin BR.
    Pharmacol Biochem Behav; 1997 Jan; 57(1-2):7-12. PubMed ID: 9164547
    [Abstract] [Full Text] [Related]

  • 23. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.
    Silva NR, Gomes FV, Fonseca MD, Mechoulam R, Breuer A, Cunha TM, Guimarães FS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct 03; 79(Pt B):369-377. PubMed ID: 28720466
    [Abstract] [Full Text] [Related]

  • 24. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.
    Lichtman AH, Fisher J, Martin BR.
    Pharmacol Biochem Behav; 2001 Oct 03; 69(1-2):181-8. PubMed ID: 11420084
    [Abstract] [Full Text] [Related]

  • 25. Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system side-effects.
    Rahn EJ, Thakur GA, Wood JA, Zvonok AM, Makriyannis A, Hohmann AG.
    Pharmacol Biochem Behav; 2011 Jun 03; 98(4):493-502. PubMed ID: 21382397
    [Abstract] [Full Text] [Related]

  • 26. Molecular Targets of the Phytocannabinoids: A Complex Picture.
    Morales P, Hurst DP, Reggio PH.
    Prog Chem Org Nat Prod; 2017 Jun 03; 103():103-131. PubMed ID: 28120232
    [Abstract] [Full Text] [Related]

  • 27. Pure Δ9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ9-tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages.
    Romano B, Pagano E, Orlando P, Capasso R, Cascio MG, Pertwee R, Marzo VD, Izzo AA, Borrelli F.
    Pharmacol Res; 2016 Nov 03; 113(Pt A):199-208. PubMed ID: 27498155
    [Abstract] [Full Text] [Related]

  • 28. Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.
    Kinsey SG, Wise LE, Ramesh D, Abdullah R, Selley DE, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2013 Jun 03; 345(3):492-501. PubMed ID: 23412396
    [Abstract] [Full Text] [Related]

  • 29. Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat.
    Craft RM, Kandasamy R, Davis SM.
    Pain; 2013 Sep 03; 154(9):1709-1717. PubMed ID: 23707295
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.
    Burgos E, Pascual D, Martín MI, Goicoechea C.
    Eur J Pain; 2010 Jan 03; 14(1):40-8. PubMed ID: 19318283
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.
    Wiley JL, Marusich JA, Lefever TW, Grabenauer M, Moore KN, Thomas BF.
    Neuropharmacology; 2013 Dec 03; 75():145-54. PubMed ID: 23916483
    [Abstract] [Full Text] [Related]

  • 36. Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.
    Thomas A, Stevenson LA, Wease KN, Price MR, Baillie G, Ross RA, Pertwee RG.
    Br J Pharmacol; 2005 Dec 03; 146(7):917-26. PubMed ID: 16205722
    [Abstract] [Full Text] [Related]

  • 37. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
    Wise LE, Thorpe AJ, Lichtman AH.
    Neuropsychopharmacology; 2009 Aug 03; 34(9):2072-80. PubMed ID: 19322169
    [Abstract] [Full Text] [Related]

  • 38. Tolerance and cross-tolerance to cannabinoids in mice: schedule-controlled responding and hypothermia.
    Singh H, Schulze DR, McMahon LR.
    Psychopharmacology (Berl); 2011 Jun 03; 215(4):665-75. PubMed ID: 21246187
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.